LGST
NASDAQ:LGSTW
Semper Paratus Acquisition Corporation
- Stock
4.51
−0.66%
−0.03
news - Apr 15, 2024
Namibia's Paratus launches fibre network between Joburg and Europe
Paratus, a Namibian telecom operator, has launched a fibre network route from Johannesburg to Europe using Google's Equiano undersea cable infrastructure, aiming to provide an alternative for local network operators to route their internet traffic.
businesslive.co.zanews - Feb 21, 2024 - 02:14
Semper Paratus Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K
Semper Paratus Acquisition Corporation held an Extraordinary General Meeting on December 14, 2023, where shareholders approved the Extension Amendment Proposal to amend the Amended and Restated Memorandum and Articles of Association. The company subsequently filed the Amended Charter with the Registrar of Companies in the Cayman Islands.
marketscreener.comnews - Feb 21, 2024 - 02:14
Semper Paratus Acquisition Corporation Announces Chief Financial Officer Changes
Semper Paratus Acquisition Corporation (Semper Paratus), a blank check company, has announced changes in its Chief Financial Officer. The company is focused on potential mergers, acquisitions, or similar business combinations within the transportation, supply chain, and logistics industry.
marketscreener.comnews - Feb 14, 2024
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be ...
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy biotech company, has completed its business combination with Semper Paratus Acquisition Corporation, forming Tevogen Bio Holdings Inc. The company's common stock and warrants will trade on Nasdaq under TVGN and TVGNW, respectively, starting February 15, 2024. Tevogen Bio aims to accelerate the development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations in virology, oncology, and neurology.
globenewswire.comnews - Feb 01, 2024 - 13:15
Semper Paratus Acquisition Corporation’s Shareholders
Semper Paratus Acquisition Corporation's shareholders have approved the proposed business combination with Tevogen Bio Inc. The combined company is expected to begin trading on Nasdaq under the symbol 'TVGN'. Tevogen Bio is a clinical-stage specialty immunotherapy company focusing on developing precision T cell therapies.
globenewswire.comDescription
Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the transportation, supply chain, and logistics industries. The company was incorporated in 2021 and is based in New York, New York.
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus